Imagion Biosystems Ltd (IBX) — Cash Flow-to-Debt Ratio
Imagion Biosystems Ltd (IBX) has a Cash Flow-to-Debt Ratio of -0.54x as of December 2025, meaning its operating cash flow of AU$-2.27 Million could theoretically repay -1% of its total liabilities (AU$4.21 Million) in one year. See Imagion Biosystems Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Imagion Biosystems Ltd Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Imagion Biosystems Ltd across 12 annual periods. Also explore IBX shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Imagion Biosystems Ltd (2014–2025)
Year-by-year debt coverage analysis for Imagion Biosystems Ltd. For market capitalisation and broader financial context, see market cap of Imagion Biosystems Ltd.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.96x | AU$-4.04 Million | AU$4.21 Million | ▼ -284.9% |
| 2024 | -0.25x | AU$-1.27 Million | AU$5.09 Million | ▲ +74.8% |
| 2023 | -0.99x | AU$-8.32 Million | AU$8.37 Million | ▲ +34.8% |
| 2022 | -1.52x | AU$-8.07 Million | AU$5.30 Million | ▲ +75.6% |
| 2021 | -6.26x | AU$-5.07 Million | AU$809.88K | ▼ -63.1% |
| 2020 | -3.84x | AU$-4.62 Million | AU$1.21 Million | ▼ -74.2% |
| 2019 | -2.20x | AU$-4.18 Million | AU$1.90 Million | ▲ +64.3% |
| 2018 | -6.17x | AU$-8.13 Million | AU$1.32 Million | ▲ +39.1% |
| 2017 | -10.13x | AU$-6.98 Million | AU$688.77K | ▼ -1613.3% |
| 2016 | -0.59x | AU$-267.26K | AU$451.99K | ▼ -35.1% |
| 2015 | -0.44x | AU$-4.22 Million | AU$9.65 Million | ▲ +22.4% |
| 2014 | -0.56x | AU$-2.43 Million | AU$4.31 Million | — |